Exelixis Inc. (EXEL)

AI Score

Unlock

35.62

-0.57 (-1.58%)

At close: Apr 21, 2025, 3:59 PM

35.45

-0.49%

After-hours: Apr 21, 2025, 05:21 PM EDT

Dividends

No dividend history available for Exelixis Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

EXEL News

5 days ago · Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term - zacks.com
1 week ago · Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - zacks.com
1 week ago · Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - zacks.com
2 weeks ago · The Smartest Biotech Stocks to Buy With $50 - fool.com
3 weeks ago · FDA Expands Exelixis Cabometyx Label for Neuroendocrine Tumors - zacks.com
3 weeks ago · Exelixis Stock Rises 13.3% Year to Date: Buy, Sell or Hold? - zacks.com
3 weeks ago · Here's Why Exelixis (EXEL) is a Strong Growth Stock - zacks.com
3 weeks ago · Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors - businesswire.com
3 weeks ago · Exelixis to Present Positive Preclinical Data Across Its Pipeline Portfolio for Advanced Cancers at AACR 2025 - businesswire.com
4 weeks ago · Biotech Leader Exelixis Eyes Buy Point In Monday's Stock Market Rally - investors.com